Physician profile
Patricio Espinosa
NPI 1861697948
$245,108.02
in general payments reported to CMS, 2019-2025
100 companies · $72K in 2025
The $72K reported for 2025 was more than what 99% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,632 · 2020: $4,905 · 2021: $48K · 2022: $20K · 2023: $39K · 2024: $57K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $86K · Food and Beverage: $37K · Consulting Fee: $32K · Travel and Lodging: $8,865 · Honoraria: $3,713 · Education: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $85,603.50 |
| Food and Beverage | $37,258.69 |
| Consulting Fee | $32,317.50 |
| Travel and Lodging | $8,865.34 |
| Honoraria | $3,712.50 |
| Education | $305.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $45,036.46 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $29,931.96 | 2020-2021 | |
| Livanova USA, INC. | $27,530.49 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy Symmetry Model 8103 Generator |
| Emd Serono, INC. | $27,293.15 | 2019-2025 | Mavenclad, Mavenclad |
| Pfizer INC. | $20,071.02 | 2021-2025 | |
| Argenx US, INC. | $12,066.96 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $7,990.32 | 2019-2025 | Uplizna, Aimovig |
| Genzyme Corporation | $7,782.59 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $5,852.19 | 2019-2025 | Dysport |
| Allergan, INC. | $4,882.38 | 2019-2022 | |
| Abbott Laboratories | $4,441.07 | 2019-2025 | Aveir, Jot Dx, Confirm Rx |
| Grifols USA, LLC | $4,371.29 | 2019-2024 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $4,210.92 | 2019-2025 | Ultomiris, Soliris |
| Axsome Therapeutics, INC. | $3,961.01 | 2025 | Symbravo |
| Biohaven Pharmaceutical Holding Company Ltd. | $3,478.30 | 2022 |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $3,122.33 | 2019-2025 | Fintepla, Zilbrysq, Briviact |
| Biogen, INC. | $2,976.84 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Aquestive Therapeutics, INC. | $2,217.99 | 2019-2022 | |
| Eisai INC. | $2,106.24 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $2,073.00 | 2019-2025 | Kesimpta |
| Lilly USA, LLC | $1,597.81 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Teva Pharmaceuticals USA, INC. | $1,237.60 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Mdd US Operations, LLC | $1,085.50 | 2019-2025 | Apokyn, Apokyn |
| Genentech USA, INC. | $1,034.65 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Evrysdi |
| Merz Pharmaceuticals, LLC | $1,011.65 | 2021-2025 | Xeomin, Inbrija |
| Takeda Pharmaceuticals U.S.A., INC. | $1,010.72 | 2021-2025 | Hyqvia, Gammagard |
| Neurelis, INC. | $987.02 | 2020-2025 | Valtoco |
| Hyperfine Operations, INC. | $882.52 | 2025 | Swoop |
| Csl Behring | $841.80 | 2019-2025 | Hizentra |
| Neurocrine Biosciences, INC. | $780.43 | 2019-2025 | Ingrezza, Ongentys |
| Amneal Pharmaceuticals LLC | $746.77 | 2019-2025 | Crexont, Rytary, Ongentys |
| Acadia Pharmaceuticals INC | $684.31 | 2019-2025 | Nuplazid, Daybue |
| Harmony Biosciences LLC | $630.93 | 2021-2025 | Wakix |
| Lundbeck LLC | $626.42 | 2019-2025 | Vyepti, Rexulti |
| Janssen Pharmaceuticals, INC | $568.20 | 2019-2023 | Xarelto, Ponvory |
| Corium, LLC | $546.83 | 2022-2023 | Adlarity, Azstarys |
| Alnylam Pharmaceuticals INC. | $542.98 | 2019-2025 | Amvuttra, Onpattro, Givlaari |
| Astrazeneca Pharmaceuticals Lp | $533.61 | 2021-2025 | Wainua |
| Celgene Corporation | $477.54 | 2021-2025 | Zeposia |
| E.R. Squibb & Sons, L.L.C. | $473.92 | 2020-2025 | Zeposia |
| Octapharma USA, INC. | $435.70 | 2021-2025 | Panzyga |
| Medtronic, INC. | $366.50 | 2021-2024 | Intellis Adaptivestim, Percept Pc Brainsense |
| Jazz Pharmaceuticals INC. | $362.75 | 2022-2024 | Epidiolex |
| Scilex Pharmaceuticals INC. | $347.56 | 2023-2024 | Ztlido |
| Sk Life Science, INC. | $299.33 | 2021-2025 | |
| Tanabe Pharma America, INC. | $290.07 | 2019-2025 | Radicava |
| Janssen Biotech, INC. | $263.15 | 2025 | |
| Kyowa Kirin, INC. | $253.21 | 2020-2024 | Nourianz |
| Ani Pharmaceuticals, INC. | $252.26 | 2023-2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $249.67 | 2025 | |
| Tg Therapeutics, INC. | $246.25 | 2023-2025 | |
| Almatica Pharma LLC | $246.00 | 2021-2023 | Gralise |
| Otsuka America Pharmaceutical, INC. | $243.93 | 2023-2025 | Nuedexta, Rexulti |
| Horizon Therapeutics Plc | $224.82 | 2022-2023 | Uplizna |
| Sunovion Pharmaceuticals INC. | $206.61 | 2019-2022 | |
| Catalyst Pharmaceuticals, INC. | $205.48 | 2020-2024 | Firdapse, Fycompa |
| Acorda Therapeutics, INC | $200.10 | 2019-2024 | Inbrija, Ampyra |
| Mallinckrodt Hospital Products INC. | $189.80 | 2022-2025 | Acthar |
| Medtronic Vascular, INC. | $176.02 | 2019 | |
| C2n Diagnostics, LLC | $166.05 | 2025 | Precivityad2 |
| Akcea Therapeutics, INC. | $157.10 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $131.36 | 2025 | |
| Impel Pharmaceuticals INC. | $126.12 | 2022-2023 | Trudhesa |
| Avid Radiopharmaceuticals, INC. | $125.00 | 2025 | |
| Greenwich Biosciences, INC. | $122.97 | 2019-2021 | |
| Avion Pharmaceuticals | $109.13 | 2022-2023 | Dhivy |
| Supernus Pharmaceuticals, INC. | $108.75 | 2021-2024 | Qelbree |
| Insightec,INC | $92.90 | 2024-2025 | Exablate |
| Merz North America, INC. | $86.99 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $79.70 | 2022 | |
| Boston Scientific Corporation | $77.47 | 2019-2024 | Watchman Flx |
| Dynasplint Systems INC. | $68.97 | 2022-2024 | Dynasplint |
| Biocomposites INC | $58.15 | 2020 | |
| Amylyx Pharmaceuticals, INC. | $55.83 | 2023 | Relyvrio |
| Invivyd INC | $54.49 | 2025 | Pemgarda |
| Kedrion Biopharma, INC. | $48.96 | 2024-2025 | Gammaked, Kedrab, Koate |
| Banner Life Sciences, LLC | $45.76 | 2021-2022 | |
| Bio Products Laboratory USA, INC. | $45.33 | 2023 | Gammaplex, Coagadex |
| Aprecia Pharmaceuticals, LLC | $42.85 | 2022 | |
| Vanda Pharmaceuticals INC. | $40.70 | 2024-2025 | Ponvory |
| Ceribell, INC. | $39.45 | 2020-2024 | Pocket Eeg Device |
| Avanir Pharmaceuticals, INC. | $38.28 | 2019 | |
| Xeris Pharmaceuticals, INC. | $37.92 | 2025 | Keveyis |
| Merck Sharp & Dohme LLC | $37.39 | 2023 | Welireg, Belsomra |
| Life Molecular Imaging Ltd | $34.89 | 2025 | Neuraceq |
| Nevro Corp. | $30.79 | 2024 | Senza |
| Alfasigma USA, INC. | $23.32 | 2022 | |
| Integra Lifesciences Corporation | $22.88 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.84 | 2019 | |
| Revance Therapeutics, INC. | $22.61 | 2025 | Daxxify |
| Mallinckrodt Enterprises LLC | $22.52 | 2019 | |
| Azurity Pharmaceuticals, INC. | $22.45 | 2024 | Horizant |
| Sumitomo Pharma America, INC. | $20.87 | 2023 | Aptiom |
| Saol Therapeutics INC. | $19.43 | 2019 | |
| Neuropace, INC. | $19.40 | 2019 | |
| Microtransponder, INC. | $18.40 | 2025 | |
| Promius Pharma LLC | $16.67 | 2019 | |
| Sandoz INC. | $15.71 | 2023 | |
| Cycle Pharmaceuticals INC | $15.34 | 2025 | Bafiertam, Tascenso Odt |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,800.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricio Espinosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.